Food, drugs, devices › Hill-Rom, Inc.
Device recall: Liko Mobile Lifts: Primarily intended for use in nursing homes Liko M220, Model 2050010
FDA enforcement event 89414 is a device recall by Hill-Rom, Inc. of Batesville, IN, initiated 23 Dec 2021 and classified Class II, with 2 product records.
FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 89% of the 900 device enforcement events initiated in 2021 carry the same class.
Status: Ongoing. Initiation: voluntary: firm initiated. Hill-Rom, Inc. has 28 enforcement events on this register, with a median of 1 product record per event.
Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.
Recalling firm
Hill-Rom, Inc., Batesville, IN.
Reason for recall
"Missing bushing on Liko M220 and M230 causing wear and potential for patient falling"
Distribution
"Worldwide distribution - US Nationwide and the countries of Austria, Austria, Bahrain, Canada, Switzerland, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Hong Kong, Ireland,…"
Product records
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| Z-0639-2022 | Liko Mobile Lifts: Primarily intended for use in nursing homes Liko M220, Model 2050010 | 5470 units | Class II | Ongoing | 23 Feb 2022 |
| Z-0640-2022 | Liko Mobile Lifts: Primarily intended for use in nursing homes LikoM230 Model: 2050015 | 1215 units | Class II | Ongoing | 23 Feb 2022 |
Context
Other enforcement events for Hill-Rom, Inc.
All 28 events for Hill-Rom, Inc.
Questions and answers
Why was this device recalled?
FDA's record gives the reason for recall as: "Missing bushing on Liko M220 and M230 causing wear and potential for patient falling"
What does Class II mean?
FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Where was the product distributed?
FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide and the countries of Austria, Austria, Bahrain, Canada, Switzerland, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Hong Kong, Ireland,…"
Is the recall still ongoing?
FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.
Where does this data come from?
openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.
Provenance
Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.